# Guanfacine to Reduce Stress-Induced Cocaine/Alcohol Craving and Relapse

> **NCT00585754** · PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 75 (actual)

## Conditions studied

- Cocaine Dependent
- Alcohol Dependent

## Interventions

- **DRUG:** Guanfacine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00585754
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2016-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00585754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00585754, "Guanfacine to Reduce Stress-Induced Cocaine/Alcohol Craving and Relapse". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00585754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*